Radient Technologies Inc (RDDTF)
0.00
USD |
OTCM |
May 21, 16:00
Radient Technologies Shareholders Equity (Quarterly): -11.06M for Dec. 31, 2022
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
December 31, 2022 | -11.06M |
September 30, 2022 | -9.99M |
June 30, 2022 | -9.029M |
March 31, 2022 | -8.111M |
December 31, 2021 | -6.142M |
September 30, 2021 | -4.632M |
June 30, 2021 | -3.647M |
March 31, 2021 | -2.004M |
December 31, 2020 | 7.571M |
September 30, 2020 | 13.56M |
June 30, 2020 | 15.71M |
March 31, 2020 | 13.41M |
December 31, 2019 | 27.89M |
September 30, 2019 | 30.65M |
June 30, 2019 | 35.24M |
March 31, 2019 | 38.08M |
December 31, 2018 | 40.28M |
September 30, 2018 | 44.64M |
June 30, 2018 | 20.91M |
March 31, 2018 | 20.03M |
December 31, 2017 | 21.40M |
September 30, 2017 | 4.967M |
Date | Value |
---|---|
June 30, 2017 | 4.592M |
March 31, 2017 | 3.296M |
December 31, 2016 | -1.660M |
September 30, 2016 | -4.920M |
June 30, 2016 | -5.105M |
March 31, 2016 | -4.735M |
December 31, 2015 | -4.168M |
September 30, 2015 | -4.027M |
June 30, 2015 | -3.411M |
March 31, 2015 | -2.718M |
December 31, 2014 | 2.318M |
September 30, 2014 | 3.690M |
June 30, 2014 | 5.563M |
December 31, 2013 | 0.3253M |
September 30, 2013 | 0.397M |
June 30, 2013 | 0.4049M |
March 31, 2013 | 0.4318M |
December 31, 2012 | 0.469M |
September 30, 2012 | 0.4861M |
June 30, 2012 | 0.4725M |
March 31, 2012 | 0.5075M |
September 30, 2011 | 0.0961M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-11.06M
Minimum
Dec 2022
35.24M
Maximum
Jun 2019
5.961M
Average
-2.004M
Median
Mar 2021
Shareholders Equity (Quarterly) Benchmarks
Acasti Pharma Inc | 64.68M |
Aurinia Pharmaceuticals Inc | 377.95M |
Edesa Biotech Inc | 4.324M |
Lexaria Bioscience Corp | 6.521M |
Liminal Biosciences Inc (DELISTED) | 16.20M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 20.63M |
Total Liabilities (Quarterly) | 31.69M |